We serve 3-Bromoanisole CAS:2398-37-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like 3-Bromoanisole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,m-Bromophenyl methyl ether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-Bromoanisole Use and application,m-Bromoanisole technical grade,usp/ep/jp grade.
Related News: Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.(2-bromo-4-fluorophenyl)methanol manufacturer In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol supplier In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.2,2,4,4,6,6-Hexamethyl-S-trithiane vendor In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?
